Beyond Traditional Structure-Based Drug Design: The Role of Iron Complexation, Strain, and Water in the Binding of Inhibitors for Hypoxia-Inducible Factor Prolyl Hydroxylase 2

[Image: see text] A combination of structure-based drug design and medicinal chemistry efforts led us from benzimidazole-2-carboxamide with modestly active hypoxia-inducible factor prolyl hydroxylase 2 inhibition to certain benzimidazole-2-pyrazole carboxylic acids that were more potent as well as o...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:ACS Omega
Main Authors: Bembenek, Scott D., Venkatesan, Hariharan, Peltier, Hillary M., Rosen, Mark D., Barrett, Terrance D., Kanelakis, Kimon C., Palomino, Heather L., Brondstetter, Theresa I., Mirzadegan, Taraneh, Rabinowitz, Michael H.
Formato: Artigo
Idioma:Inglês
Publicado: American Chemical Society 2019
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6547624/
https://ncbi.nlm.nih.gov/pubmed/31179408
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsomega.9b00199
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares